Clinical Oncology
Volume 18, Issue 6 , Pages 447-452 , August 2006

Wide Local Excision and Radiotherapy for the Treatment of Ductal Carcinoma in situ of the Breast: the Hong Kong Experience

  • T.K. Yau

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
    • Corresponding Author InformationAuthor for correspondence: Dr Tsz-Kok Yau, Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong Kong. Tel: +852-25954174; Fax: +852-29045216.
  • ,
  • K. Chan

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
  • ,
  • M. Chan

      Affiliations

    • Breast Center, Department of Surgery, Kwong Wah Hospital, Hong Kong
  • ,
  • H.W. Lau

      Affiliations

    • Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong
  • ,
  • I.S. Soong

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
  • ,
  • P. Cheung

      Affiliations

    • Breast Care Center, Hong Kong Sanatorium and Hospital, Hong Kong
  • ,
  • A.T.Y. Chang

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
  • ,
  • A.W.M. Lee

      Affiliations

    • Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong

Received 12 February 2006 ,Revised 17 March 2006 ,Accepted 2 April 2006.

References 

  1. Schnitt SJ, Harris JR, Sith BL. Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet?. Cancer. 1996;77:2189–2192
  2. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer. 1999;85:616–628
  3. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer. 1999;86:429–438
  4. Julien JP, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet. 2000;355:528–533
  5. Ernster VL, Barclay J, Kerlikowske K, et al. Incidence of and treatment of ductal carcinoma in situ of the breast. JAMA. 1996;275:913–918
  6. Crofts TJ. Management of breast cancer in Hong Kong. Hong Kong Pract. 1986;8:1805–1809
  7. Yau TK, Lau Y, Kong J, et al. Breast conservation treatment in Hong Kong – early results of 203 patients: retrospective study. Hong Kong Med J. 2002;8:322–328
  8. Joslyn SA. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival. Breast J. 2006;12:20–27
  9. Winchester DP, Cox JD. Standards for breast-conservation treatment. CA Cancer J Clin. 1992;42:134–162
  10. Wun LM, Feuer EJ, Miller BA. Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States?. Cancer Causes Control. 1995;6:135–144
  11. Fonseca R, Hartmann LC, Petersen IA, et al. Ductal carcinoma in situ of the breast. Ann Intern Med. 1997;127:1013–1022
  12. Chua MS, Mok TS, Kwan WH, et al. Knowledge, perceptions, and attitudes of Hong Kong Chinese women on screening mammography and early breast cancer management. Breast J. 2005;11:52–56
  13. Vargas C, Kestin L, Go N, et al. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys. 2005;63:1514–1521
  14. Kinne DW, Petrek JA, Osborne MP, et al. Breast carcinoma in situ. Arch Surg. 1989;124:33–36
  15. Morrow M, Strom EA, Bassett LW, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002;52:256–276
  16. Camp R, Feezor R, Kasraeian A, et al. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida. Breast J. 2005;11:394–397
  17. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16:441–452
  18. Silverstein MJ, Lagios MD, Craig PH, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77:2267–2274
  19. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340:1455–1461
  20. de Mascarel I, Bonichon F, MacGrogen G, et al. Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: fractional considerations. Breast Cancer Res Treat. 2000;61:151–159
  21. Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006;24:1031–1036
  22. Kunos C, Latson L, Overmoyer B, et al. Breast conservation surgery achieving ≥2 mm tumor-free margins results in decreased local-regional recurrence rates. Breast J. 2006;12:28–36
  23. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999;353:1993–2000
  24. Kestin LL, Goldstein NS, Martinez AA, et al. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results. Ann Surg. 2000;231:235–245
  25. Silverstein MJ, Barth A, Poller DN, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer. 1995;31A:1425–1427
  26. Hiramatsu H, Bornstein BA, Recht A, et al. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ. Cancer J Sci Am. 1995;1:55–61

PII: S0936-6555(06)00154-3

doi: 10.1016/j.clon.2006.04.003

Clinical Oncology
Volume 18, Issue 6 , Pages 447-452 , August 2006